ORIGINAL
Cardiopulmonary bypass (CPB) remains the key technology for more complex cardiac operations. Despite tremendous progress since its introduction into clinical practice, CPB is still far from perfect and hence continuous efforts to study and improve hemocompatibilityof both conduct and components of CPB are crucial. The problem is cardiac surgery in conjunction with cardiopulmonary bypass in its current form restricts the patient to exit the hospital in 5-7 days. We know that conventional standard bypass triggers the release of inflammatory mediator which elongates patient’s length of stay. The Pinnacle System tricks red blood cells, platelets, proteins and inflammatory mediators ...
